Ganesha (G or G-0), also known as 3,4-dimethyl-2,5-dimethoxyamphetamine or as 3-methyl-DOM, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families. http://www.erowid.org/library/books_online/pihkal/pihkal085.shtml It is the 3-methyl derivative of DOM and the amphetamine (α-methyl) derivative of 2C-G. The drug is taken orally.
Use and effects In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists Ganesha's dose range as 24 to 32mg orally and its duration as 18 to 24hours. The drug's onset was variably described as slow over the course of 3hours or as rapid. The effects of Ganesha have been reported to include strong closed-eye visuals, an increased appreciation of music, and powerful relaxation and tranquility, among others. Shulgin named Ganesha after the Hindu deity, Ganesha. It is one of his "ten classic ladies", a series of methylated DOM derivatives.
Interactions
Chemistry Synthesis The chemical synthesis of Ganesha has been described.
Homologues
Homologues of Ganesha (G-0) include G-3, G-4, G-5, and G-N, among others.
Compound Details Structure G-3 CAS #: 207740-36-1 Dose: 12–18mg Duration: 8–12hours Effects: Closed-eye imagery, no visuals, fantasy, no body load, neurological sensitivity, others 2C analogue: 2C-G-3 G-4 CAS #: Unknown Partially synthesized but not tested. 2C analogue: 2C-G-4 G-5 CAS #: 133787-68-5 Dose: 14–20mg Duration: 16–30hours Effects: No visuals or other sensory effects, excellent mental activity, mental integration, lacking something important, little or no body load 2C analogue: 2C-G-5 G-N CAS #: 477904-62-4 Synthesized and tested at 2mg but not up to active levels 2C analogue: 2C-G-N G-OHellberg MR, Namil A. Benzopyran analogs and their use for the treatment of glaucoma. Patent US 7396856 CAS #: 774538-38-4 Described and/or synthesized but not tested 2C analogue: None
History Ganesha was first described in the literature by Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) in 1991.
Society and culture Legal status Canada Ganesha is a controlled substance in Canada under phenethylamine blanket-ban language.
United Kingdom This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.
United States Ganesha is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption. In addition, the drug may considered a controlled substance as a positional isomer of DOET.
See also DOx (psychedelics) Juno (6-methyl-DOM) DOTMA (3,6-dimethyl-DOM) DODC (3-chloro-DOC) DODB (6-bromo-DOB) 2-Methylmescaline
References
External links Ganesha - Isomer Design Ganesha - PiHKAL - Erowid Ganesha - PiHKAL - Isomer Design